Intezer, a cybersecurity company, closed a $15 million Series B funding round led by OpenView.
Intel Capital, Magma, Samsung NEXT, a USAA affiliate, and Alon Cohen – the founder and former CEO of CyberArk, and co-founder of Intezer – also participated in the round.
The Series B funding announcement comes one week after Intezer unveiled its new runtime cloud security product, Intezer Protect, which is based on its core Genetic Malware Analysis technology. The company also appointed industry veteran and former CyberArk CRO Ron Zoran to its board of directors.
According to the company, its Genetic Malware Analysis platform allows organizations to detect and classify cyber attacks by identifying the threats’ software origins. Identifying the source of the attack itself effectively decreases the ROI for cybercriminals, making it exponentially harder for them to launch a new attack campaign.
Intezer serves a diverse client portfolio, including Fortune 500 companies, modern startups, and elite government agencies. In 2019, the company publicly uncovered many previously undetected cyber threats while observing an increase in the number of Linux and cloud-focused attacks in the wild. Among the company’s discoveries were large scale crypto-mining campaigns, botnets, ransomware, and nation-state sponsored threats, including HiddenWasp, QNAPCrypt, and PureLocker.
Tevet, CEO and co-founder of Intezer, said: “We will use the latest funding to accelerate our sales growth and expand the technology into the larger threat protection market.”
“While Genetic Malware Analysis is a relatively new category, we’ve seen more vendors incorporating this approach into their cybersecurity solutions. This new financing round will enable Intezer to strengthen its market leadership and product offerings to accelerate the global market adoption of Genetic Malware Analysis,” said Alon Cohen, founder and former CEO of CyberArk, and chairman at Intezer.